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Complex multi-cellular organisms are subjected to a constant bombardment from a wide 
array of pathogenic agents. As a consequence they have evolved a large arsenal of 
defense mechanisms. The highly efficient first line of defense consists of the epithelial 
layers of the skin, and the mucosal surfaces of the gut and airways, which provide 
mechanical, chemical and also biological protection. Unfortunately, as evolution has 
provided us a means of defense, it has also provided the pathogens the ability to penetrate 
our defenses. The immune system has evolved to facilitate the removal of the pathogens 
that are successful in penetrating our outer parameters. It is generally divided into two 
parts, the innate and the adaptive immune systems, there is however considerable 
crosstalk between the two. 
The innate immune system consists of an array of specialized cells which recognize 
general characteristics common to many pathogens (PAMPs; pathogen associated 
molecular patterns) through a wide array of cell surface receptors (PRRs; pattern 
recognition receptors). Cells of the innate immune system includes macrophages, 
neutrophils and natural killer (NK) cells, but also lymphocytes with an innate like 
behavior such as B1 cells (produce natural antibodies), epithelial γ:δ T cells (which 
recognize MHC-1B ligands) and natural killer T (NKT) cells (are activated in response to 
lipid antigens presented on CD1d). The complement also belongs to this system and 
consists of plasma proteins which act to opsonize pathogens and induce an inflammatory 
response. 
The adaptive immune system comes into play at a later stage during the immune 
response. It is divided into two parts characterized by the production of antigen specific 
antibodies (the humoral) and the activation of antigen specific cytotoxic T cells (the T 
cell mediated). Both involve genetic recombination and selection, and both are highly 
specific for the pathogen encountered. 
Adaptive immunity requires the presentation of pathogen derived peptides on the major 
histocompatibility (MHC) class I or class II molecules. MHC class I molecules are 
present on all nucleated cells and present peptides derived from pathogens resident in the 
cytosol. They react with the T cell receptor (TcR) on CD8+ T lymphocytes, alerting them  
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Figure 1. Differential activation of naïve T cells. Figure obtained from Kapsenberg, Nat Rev Immunol. (2003). Immature DCs 
polarized by type 1, type 2 and regulatory-type PAMPs or tissue factors (TFs) to become mature effector DCs that promote the 
development of naive T cells into TH1, TH2 or regulatory T cells. DC-polarizing tissue factors can be produced by various 
resident tissue cells and immune cells. These cells will produce type 1, type 2 or regulatory TFs depending on their origin or 
the way in which they are activated. TGF-β; transforming growth factor-β, CCL; CC-chemokine ligand, CCR; CC-chemokine 
receptor, PGE2; prostaglandin E2, TCR; T-cell receptor, TNF-β; tumour-necrosis factor-β. 
 
 
to the presence of danger and provoking a cytotoxic response1. Expression of MHC class 
II molecules, on the other hand, is normally restricted to a limited number of cell types, 
termed “Professional Antigen Presenting Cells” (APCs)2. Their expression can however 
be induced on other cells in response to specific stimuli such as IFNγ. B cells are not 
considered to be very efficient APCs, the reason for which is that they only efficiently 
take up antigens recognized by their highly specific membrane bound IgM (mIgM). 
Considering the low frequency of specific B cell clones (before activation), the chance 
that they should encounter their respective T cell counterpart is extremely low. 
Macrophages however phagocytose pathogens indiscriminately and are therefore much 
more likely to present specific peptide MHC combinations recognized by many 
circulating T cells. Amongst APCs the Dendritic cells (DCs) are exceptional in their 
presentation capacity and warrants a special mention here. Many subpopulations of DCs 
have been characterized3,4, with various varying functions attributed, but a simplified 
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description will suffice here. DCs reside or traverse throughout the various tissues of the 
body where they act as sentinels, constantly sampling their environment for danger 
signals. When activated by the encounter of antigen or cytokines, they undergo a 
remarkable differentiation, termed maturation. From being mostly tissue resident, they 
now display on their surfaces homing receptors for migrating to lymph nodes where large 
numbers of naïve T cells resides, and which they become the most potent activators of. 
They also display an astonishing morphological differentiation whereby their MHC class 
II molecules, which in immature DCs (imDCs) resides mostly intracellularly, is 
redistributed to the plasma membrane where they remain stably for several days. This 
imparts on these cells an unique ability to present an accurate “snapshot” of their 
environment at the time of activation, and reduces the potentially dangerous presentation 
of peptides present before activation5. 
MHC class II molecules present peptides derived from ingested pathogens processed in 
endocytic compartments to the TcR on CD4+ T lymphocytes. In combination with co-
stimulatory molecules and polarizing factors they will drive the expansion of Ag specific 
T cell clones toward a TH1, TH2 or TH3/regulatory T cell response, depending on the 
environment at the time of activation and the consequent polarizing factors released 
(Figure 1). A TH1 response will promote a cytotoxic T cell response, whereas a TH2 
response will drive the subsequent activation of specific B cells and consequently 
antibody production. A regulatory T cell response will repress an immune response and is 
essential in preventing autoimmunity6,7. The MHC class II molecules and especially the 












MHC class II molecules present peptides derived from exogenous antigens to the TcR on 
CD4+ T lymphocytes. The compartments of the endocytic pathway presents ingested 
antigens to a progressively lower pH and greater concentrations of proteases2. The MHC 
class II molecule consists of an α and a β chain, which after translation and translocation 
into the endoplasmatic reticulum (ER), dimerizes, forming the heterodimeric class II 
molecule. In the ER MHC class II encounters the invariant chain (Ii), trimers of Ii 
associates with three class II heterodimers forming a nonameric complex. Ii plays an 
important role in the assembly and transport of the MHC class II molecules. Via its class 
II associated invariant chain peptide (CLIP) region it blocks the peptide binding groove 
of MHC class II, preventing premature peptide binding and stabilizing the class II 
molecule. Ii contains within its cytosolic tail two sorting signals which direct the complex 
to late endosomes and lysosomes8. In the absence of Ii, class II molecules mainly bind 
peptides in early endosomal compartments9. These are far less acidic than late 
endosomes/lysosomes and contain a more sparse array of, and lower concentrations of, 
proteases. It is therefore likely that they will present a much more limited array of 
peptides than will MHC class II transported by Ii. Compartments were peptide loading 
takes place are required to have several characteristics10, rated highly amongst these is the 
presence of HLA-DM, which acts as a peptide editor, promoting the loading of tightly 
binding peptides11. In the following sections I will elaborate on the MHC class II 
molecules and the pathways employed by them. Special focus will be given to the Ii 
molecule and its unique capabilities in directing MHC class II transport. 
 
1.1 The major histocompatibility complex 
 
The MHC is a large gene complex encoding, amongst other molecules, the MHC class I 
and II glycoproteins and their accessory molecules (for a review see Horton et al. 
200412). It was first discovered in mice in 1936 for its potent effects on the immune 
response to transplanted tissues13. The first sequence based map of the human MHC, the 
human leukocyte antigen (HLA), was published in 199914 and consisted of a 3.6 
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megabase-pair (Mb) long sequence derived from many individuals with various HLA 
types, thereby producing a mosaic MHC haplotype. More recently, the boundaries of the 
HLA has been redefined, and the extended MHC (xMHC) now covers a total of 7.6 Mb 
on the short arm of chromosome 615. In contrast to the TcR and immunoglobulin (Ig) 
locus, the MHC class II genes do not undergo the extensive genetic recombination 
essential for generating high affinity binding sites. In stead, the MHC contains a huge 
number of class I and II alleles, with varying binding specificities, each able to bind a 
wide array of peptides. In fact the human leukocyte antigen (HLA) B was recently 
confirmed to be the most polymorphic gene in the human genome15, and over 100 HLA-
DRβ alleles are known. Classical human MHC class II genes consist of HLA-DR, HLA-
DP and HLA-DQ with high polymorphism within each. In the murine system two 
classical polymorphic MHC class II genes are described, I-A and I-E. The Ii gene does 
not reside within the MHC, it is in fact located on an entirely different chromosome 
(chromosome 5 in humans and 18 in mice).  
 
1.2 Transcriptional control of MHC class II genes 
 
Expression of MHC class II molecules and their accessory molecules is under highly 
stringent control by a variety of cis- and trans-acting elements (reviewed by Mach et 
al.16). The MHC class II proximal promoter region contains S, X1, X2 and Y boxes with 
sequences, orientations and spacing that are conserved for α, β, HLA-DM and Ii genes in 
various species ranging from zebra fish to mice and humans. There are however subtle 
variation within these cis-acting elements which may account for allelic differences in the 
expression levels of individual MHC class II genes17,18. In particular the Y box in the Ii 
gene is inverted with respect to the Y boxes of the other genes (HLA-DP/-DQ/-DR/-
DM/-DO) and the spacing between the X and Y box and composition of the conserved S-
X-Y module differs between HLA-DRA and Ii. This might affect the assembly of trans-
acting factors and affect Ii promotor strength19 resulting in the observed elevated 
expression of Ii as compared to MHC class II20-23. 
Several transacting factors acting on the MHC class II proximal promotor region have 
been identified, and three complexes are described. RFX is a trimeric nuclear complex 
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Figure 2 MHC-II enhanceosome on the HLA-DRa promoter. Obtained from Zika and Ting, Curr Opin Immunol. (2005). MHC-II 
promoters share a common set of cis-acting elements including the W/S, X1, X2 and Y boxes (S–X–Y module). The Y element 
binds the heterotrimeric transcription factor NF-Y. The X1 region is recognized by the RFX complex, whereas X2 is bound by 
CREB. These transcription factors are ubiquitously expressed and form an appropriate interaction surface for the recruitment of 
CIITA. CIITA also interacts with an array of TAFs and elongation factors such as pTEFb. Finally, CIITA interacts with the 
kinases CDK7 and CDK9, and enhances their ability to phosphorylate RNA polymerase II leading to initiation of mRNA 
synthesis. 
 
that binds to the X-box24, NF-Y is a heterodimer which binds CCAAT of the Y-box 
cooperatively with RFX25 and X2BP, also a heterodimeric complex which includes 
CREB26, binds the X2-box27. The three more or less ubiquitously expressed complexes 
bind cooperatively to the promoter forming a stable macromolecular nucleoprotein 
complex, termed the MHC II enhanceosome28, onto which the class II trans-activator 
(CIITA) binds. CIITA is the master regulator of MHC class II genes29,30 and controls the 
constitutive expression of MHC class II and accessory molecules31-34 in APCs as well as 
the inducible expression in other cell types. If transfected into cells, CIITA can by itself 
drive the expression of the MHC class II genes. CIITA interacts with numerous cofactors 
to modify chromatin so that the ubiquitously expressed DNA binding complexes can 
assemble on the class II promoters and form the MHC II enhanceosome35,36. Once bound 
onto the enhanceosome, CIITA interacts with components of the basal transcription 
machinery to initiate transcription of target genes (Figure 2). Three different isoforms of 
CIITA resulting from the use of four different promoters (pI-pIV) have been described37 
with varying expression levels amongst APCs as well as IFNγ induced cells29. CIITA is 
naturally itself under stringent control at the transcriptional as well as epigenic level, and 
several factors have been described that activate, modulate or repress CIITA 
expression29,38. 
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In addition to the transcriptional control of MHC class II expression as mediated by 
CIITA, there is evidence for further modulation of class II expression at the translational 
level. Stabilization of mRNA following activation with CpG has been described for 
HLA-DR in B lymphocytes39 and there is evidence implying that also the Ii mRNA 
stability may be subject to regulation40. 
 
1.3 MHC class II molecules 
 
MHC class II molecules are expressed as heterodimers of two transmembrane 
polypeptides (Figure 3). The α chain (~35kD) and a β chain (~27kD) differ in size mainly 
due to differences in N-linked glycosylation41. The α and β chain spontaneously associate 
in the ER due to interactions between their lumenal42,43 and transmembrane44 domains. 
All classical class II molecules have the same conformation, consisting of two 
extracellular domains α1 and α2, and β1 and β2 for the α and β chains, respectively. The 
peptide binding groove is composed of the membrane-distal α1 and β1 domains of the 
two chains, forming a platform of eight antiparallel β strands lined by two antiparallel α-
helices45 with a disulfide bond linking the α-helix of the β1 to the β sheet floor (β10C-
β78C). The polymorphism of MHC class 
II molecules is largely located to these 
domains. The groove of class II molecules, 
as opposed to class I, is open at the ends, 
and the C- and N-termini of bound 
peptides may therefore extend beyond the 
ends of the groove. Conserved amino acid 
side chains lining the groove form 
hydrogen bonds to the peptide backbone46, 
conferring sequence independent binding 
onto the class II molecule and enabling the 
high affinity binding of a wide range of 
peptides. There is, however, a requirement 
for the presence of certain residues in the 
Figure 3. Model of MHC class II. The lumenal domain was 
taken from a crystal structure of HLA-DR1 (Zavala-Ruiz et 
al. 2003) the transmembrane and cytosolic domains are 
modelled. See text for details.  
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peptides presented by specific class II alleles because of polymorph anchor residues 
making specific interaction with the peptide, such as has been described lacking in HA 
binding to I-Ak46. The β chain of the human and mouse class II molecules contain leucine 
based sorting signals in their cytosolic tails47,48 which are required for internalization and 
recycling of class II molecules at the plasma membrane49. Efficient assembly and 
transport of MHC class II is, however, greatly enhanced in the presence of Ii50,51.  
 
1.4 The Invariant chain molecule 
 is a type II transmembrane glycoprotein that comes in several isoforms due to 
 
Ii
alternative translation initiation sites and alternative splicing (Figure 4). The dominant 
isoform in humans is p33, it has an N-terminal cytosolic tail of 30 amino acids, a 
transmembrane domain consisting of residues 31-56, and a C-terminal lumenal domain of 
160 amino acids. The p35 form of Ii results from use of the alternative translation 
initiation site and adds 16 amino acids to the N-terminal cytosolic tail52,53, these 
additional residues confer an ER retention signal (R-X-R) onto the isoform54,55, which 
may be overcome through interaction with the cytosolic tail of the HLA-DRβ chain56. 
The p33 and p35 isoforms generate the p41 and p43 forms through alternative splicing of 
exon 6, resulting in a 64 residue insertion into the lumenal domain encoded by exon 
6b52,53,57. Ii contains both N-linked and O-linked glycosylation sites and can be both  
 
 
Figure 4. Invariant chain isoforms. Adapted from Gregers et al. Intracellular Pathogens in Membrane Interactions and Vacuole 
Biogenesis (2003). See text for details. 
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phosphorylated and modified by addition of chondroitin sulfate moieties (reviewed 
in8,58,59). Ii forms trimers in the ER due to trimerization domains located in the 
transmembrane (TM) segment60 and in the lumenal domain C-terminal to CLIP (residues 
163-183)61,62(Figure 5). The biological significance of Ii trimer formation is not definitely 
established. Class II association and interaction with adaptor proteins proceeds normally 
if trimerization is inhibited63, but presentation of certain peptides is abolished64 indicating 
that trimerization is important for antigen presentation to T cells. Trimerization is 
however a requirement for formation of the Ii-induced enlarged endosomal vesicles61 
(I  
peptide loading. Ii is a multifunctional molecule and in addition to its conventional 
 II under 
onditions where Ii has low affinity for the peptide binding site77, two β-strands in the 
lt-bridge between the α chain 
sidue 181 and Ii residue 74 and Ii amino acids 36-57 form electrostatic interactions with 
78
LEVs) and may therefore be involved in modulating the endocytic pathway to facilitate
properties it has been suggested as a signaling factor through the cleavage of its 
cytoplasmic tail and activation of the NF-κB pathway (reviewed in65) as a chaperone for 
HLA-DM66, and as a cell surface receptor for MIF67. This, however, lies beyond the 
scope of this text, and the reader is directed to the references for further details. 
 
1.5 The MHC class II-Invariant chain complexes 
 
Ii interacts with the class II heterodimer via several domains, the most prominent being 
the CLIP region of which the C-terminal part occupies the peptide binding groove, 
preventing premature peptide binding in the ER and golgi68-73, and the N-terminal part 
binds outside the groove, contributing to the fast off-rate of CLIP74,75. Additional 
interacting regions must be present as it has been shown that Ii can interact with class II 
even when the peptide binding groove is occupied by high affinity peptides76. A region C 
terminal to CLIP (amino acids 103-118) has been shown to interact with class
c
class II α chain form a binding pocket for Ii with a sa
re
the class II β chain . Also, the TM region of Ii has been suggested as an additional CLIP 
independent MHC class II interaction site79. The number of class II interacting domains 
that have been described so far, suggests that this interaction is of great evolutionary 




associate into a nonameric (αβIi)3 complex80 (Figure 5). The order of assembly is not 
clear, and may differ for various class II alleles81, Ii trimers either associate with pre-
formed αβ dimers80 or with α and β chains in a stepwise manner82,83. Ubiquitously 
expressed ER chaperones, such as Calnexin84,85 and BiP86, assist in the assembly of the 
(αβIi)3 complex by associating with, and retaining, the free subunits. Correctly assembled 
complexes are freed from the ER quality control system and assemble in COPII coated 
v
Figure 5. Nonameric (αβIi)3 complex. Adapted from Cresswell, cell. (1996), Kukol et al. Mol Biol. (2002) and Jasanoff et al. 
(1999). MHC class II interacting and trimerizing residues are indicated. The transmembrane trimerization motif is thought to be a 
cluster of polar residues (Q47, T49, T50, Y52) near the lumenal interface{Ashman, 1999 #228;Kukol, 2002 #743}. See text for 
further details. 
esicles for transfer to the golgi apparatus87. In the golgi, the (αβIi)3 complexes undergo
urther modification of sugar side chains and are acetylated
 
f  
phosphorylated90. These modifications are interdependent on the presence of Ii and class




complex sugars in the absence of class II92. The consequences of these modifications 
have not been conclusively established.  
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1.6 Other MHC class II accessory molecules 
 
The non-classical MHC class II molecules HLA-DM and HLA-DO (H2-M and H2-O in 
mice) are both heterodimeric proteins consisting of an α and β chain. HLA-DO is highly 
similar to the classical class II molecules HLA-DR/-DP/-DQ (60% i entical), whereas 
HLA-DM is further removed with as much similarity to class I as class II (approximately 
30%)
d
LA-DM β-chain contains in its cytosolic tail a 
rosine based sorting motif (YPTL) which targets it to the endosomal system94-96. If this 
mbrane (PM), but can be rescued 
ransported to endosomes) if Ii is present94. HLA-DM lacks peptide binding properties, 
11,93. The majority of HLA-DM resides in multi-vesicular/-lamellar endosomes 
(collectively multi-vesicular bodies (MVBs) here for simplicity), but it has been detected 
throughout the endocytic pathway. The H
ty
signal is mutated HLA-DM is blocked at the plasma me
(t
instead it interacts with MHC class II molecules, promoting the release of CLIP, 
stabilizing the empty heterodimers and facilitating the loading of high affinity peptides97-
100. The interaction between HLA-DR and HLA-DM is of low affinity and sensitive to 
pH101,102, and recent data suggest that it may be restricted to the internal structures of 
MVBs103. HLA-DO is, like HLA-DM,  mainly localized to lysosomes104-106 where it is 
associated with HLA-DM, mainly at the limiting membrane, but also on internal 
structures103,107. The long cytosolic tail of the HLA-DO β-chain contains two potential 
endosomal targeting motifs108,109 which do not seem to function in intracellular 
transport105, but may direct HLA-DO preferably to the limiting membrane of MVBs110. 
HLA-DO appears to be a pH dependent modulator of HLA-DM activity, at acidic pH 
HLA-DM/-DO complexes bind tightly to HLA-DR and enhance peptide loading110, 
whilst at pH 6.0-6.5 loading is reduced111,112, thereby promoting peptide loading 
preferably in late endosomes and lysosomes. 
Another family of proteins shown to interact with class II molecules are the tetraspanins. 
Tetraspanins are four-pass transmembrane proteins containing 4 to 6 conserved 
extracellular cysteines linked via 2 or 3 disulfide bonds, and conserved polar residues 
within their transmembrane domains (reviewed in113). Tetraspanins such as CD63 and 
CD82 interact with HLA-DR and/or HLA-DM on the internal membranes of MVBs114,115 
and CD81 interacts with HLA-DR at the plasma membrane in B cells116. The functional 
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consequences of these interactions are not clear, but these proteins could be involved in 
the segregation and/or protection of class II and accessory molecules to facilitate peptide 
loading, and targeting and/or clustering MHC class II and co-stimulatory molecules to/in 
distinct membrane domains117 to enhance antigen presentation. 
 
2.0 Endocytosis and the endosomal system 
 
As mentioned the endocytic pathway comprises a variety of compartments with a 
progressively wider array of and greater concentration of proteases. Entry into the 
endocytic pathway for exogenous components occurs via the plasma membrane and can 





Phagocytosis is a complex process involving actin driven membrane protrusions 
engulfing particles and leading to the formation of large intracellular vacuoles. It requires 
receptor mediated recognition of the particle (or complement/antibodies attached to it) 
and can lead to several outcomes depending on the nature of the particle engulfed. 
Phagocytosis requires large amounts of membranes, and early endosomes are thought to 
Figure 6. Types of endocytosis used for antigen acquisition. Phagocytosis involves the ingestion of large particles or cells. Particle 
binding to specific receptors signals actin assembly and drives pseudopod extension and particle engulfment. Macropinocytosis is 
also actin-dependent and can account for the uptake of large quantities of extracellular fluid and fluid-dissolved antigens. Soluble 
receptor-ligand complexes are typically internalized by clathrin-coated vesicles or caveolin-containing invaginations. 
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contribute to this, however, after internalization phagosomes may both obtain ER 
membranes and fuse with lysosomes.  Toll-like receptors (TLRs), MHC class II and class 
I are all recruited to phagosomes, class II present peptides from phagocytosed antigens, 
and cross-presentation of exogenous antigens on class I is greatly enhanced if antigens 
are acquired by phagocytosis. The TLRs presumably play an important role (in 
collaboration with the initial recognizing receptors) in sampling of cargo and determining 
the consequent response (reviewed in references118-120). 
Macropinocytosis occurs constitutively in immature DCs121 allowing them to rapidly and 
non-specifically sample large amounts of extracellular fluid. Macropinocytosis, is like 
phagocytosis, an actin dependent process involving membrane ruffling, mediated by ras 
G  
in  
soluble content. The maturation process occurs differently in different cell types, with
both persevering homeotypic fusion of early endosomal antigen 1 (EEA1)-
esult is fast capture and effective 
TPases122,123, and back-fusion of the membrane protrusion with the PM possibly
volving rabs124,125. This generates macropinosomes which shrink and concentrate their
 
macropinosomes126 and fusion with lysosomes described127. Antigens acquired by 
macropinocytosis can be presented on both MHC class I128 and class II molecules121. 
Caveolae are small, cholesterol rich, hydrophobic membrane domains characterized by 
the presence of caveolin. They are present on all immune cells, and several pathogens are 
internalized via these flask-shaped invaginations129. Caveolae mediated endocytosis is 
triggered by signals resulting in the tyrosine-phosphorylation of caveolin and dynamin (a 
critical component of the fission machinery), and release of the caveolin coated vesicles 
to the cytosol130-132. Caveolar vesicles may fuse with caveosomes or dock on early 
endosomes (EE), if recruited by specific small GTPases133, thereby rendering their 
content accessible to the antigen loading machinery. 
Receptor mediated endocytosis via clathrin coated pits (CCPs) requires the ligation of 
antigen with specific receptors on the cell surface. The r
concentration of a specific antigen134 as specified by the receptors present on the 
particular APC. Targeting antigens to specific receptors such as DEC-205, which is 
preferentially expressed by DCs and internalized via CCPs, causes a 100- to 1000-fold 
more efficient antigen capture and presentation than soluble antigen135,136. The repertoire 
of receptors present is therefore of essential importance for antigen presentation. 
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Receptor ligation triggers the recruitment of a number of factors to the cytosolic face of 
the PM and as much of the same machinery is involved in the internalization of MHC 
class II and accessory molecules it will be elaborated on in the following section. 
 
2.1 Cargo recruitment and membrane trafficking 
 
Endocytosis via CCPs occurs via three mechanistically distinct intermediate stages 
characterized by a) assembly of the polygonal clathrin lattice defining the coated pits, b) 
invagination and c) pinching-off and liberation of clathrin coated vesicles (CCVs). 
Cargo-proteins are recruited into CCPs by binding via specific sequences in their 
cytoplasmic tails to adaptor proteins (APs), or other coat-associated proteins such as β-
arrestin, but can also be marked for internalization by attachment of mono-ubiquitin137. 
igure 7). The AP complexes 
rmation by linking the 
mechanical clathrin coat to the 
phospholipid membrane, 
selecting and binding cargo and 
recruiting the plethora of other 
proteins involved in creating and 
disassembling a CCV’s coat140. 
AP-2 is, with clathrin, the most abundant protein found in CCPs, if AP-2 is knocked-
down by RNAi the number of 
CCPs is reduced by over 
90%138,139, indicating its 
importance in CCP formation. 
AP-2 is a heterotetramer 
consisting of four subunits (α, 
β2, µ2 and σ2) which interact 
with numerous elements 
involved in CCP formation 
(F
appear to coordinate CCV 
Figure 7. Model of AP-2 obtained from Owen et al. Annu Rev Cell Dev Biol. 
(2004). AP-2 subunits are colored α blue, σ2 gray, β2 green, and µ2 purple. 
The appendages were solved separately, and the linkers connecting them to the 
core are modeled. 
fo
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The α and µ2 domains contain PtdIns(4,5)P2 binding sites for localization of AP-2 to the 
PM, whilst the µ2 domain recognizes YxxΦ motifs in the cytoplasmic tail of cargo 
proteins after AP-2 has undergone a conformational change brought on by 
phosphorylation by AAK1141-143 and interaction with PtdIns(4,5) P2. AP-2 is also thought 
to interact with acidic dileucine motifs ([DE]xxxL[IL]) in cargo proteins via its β2144,145 
and/or µ2146 subunits and with a number of accessory proteins via their DP[FW], FxDxF 
or Wxx[FW] motifs to the α- and β2-appendanges of AP-2140.  Clathrin interacts with a 
clathrin box motif (LΦxΦ[DE]) i
CCPs/CCVs is the clathrin triskelio
arranged as a three-legged structure. In
mediated via a groove between 
blades 1 and 2 of the 7-bladed β-prop
however another non-competitive 
(W-box; binds a PWDLW motif 
assembles into lattices via intermolecu
legs of the triskelions
n the β2 subunit of AP-2147. The assembly unit of 
n, consisting of three heavy and three light chains 
teraction with APs and other accessory proteins is 
eller of the N-terminal domain of the heavy chains, 
binding site exists on the top face of the β-propeller 
present in the amphiphysins and Snx9)148. Clathrin 
lar contacts between both the distal and proximal 
ent for generating membrane 
invaginations. This is accomplished through the 
 the membrane. Amphiphysin, 
ll able to deform membranes in vitro, and clathrin 
153.  
ules forming CCPs and CCVs is not clear. A 
nation and pinching of, suggest that epsin, CALM and 
P-2 to the PM. AP-2, though its various interacting 
in
d ossibly fission) and target dynamin to 
149, there is however a requirem
curvature in order to establish 
recruitment of proteins and lipids150 which act to deform
endophilin, dynamin and epsin are a
coated buds assemble onto them151-
The precise order of assembly of the molec
current modell of assembly, invagi
Eps15 are involved in recruiting A
domains, then recruit cargo, clathr
directly promote invagination (an
CCPs. Dynamin is a GTPase which oligomerizes at the neck of invaginating pits, it is 
also involved in caveolae mediated endocytosis. Dynamin and also other CCP associated 
proteins (Intersectin, Hip1, Hip1R), may regulate actin polymerization and motor protein 
recruitment probably required for the final step of vesicle fission and propulsion of the 
nascent CCV into the cytosol, after which the clathrin coat is disassembled by Hsc70 and 
auxilin
 and other factors, and amphiphysin and endophilin 
endophilin p
154. Freed vesicles attach via adaptor proteins to motor-proteins and traffic along 
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actin filaments and microtubuli to sorting or recycling EEs155. Fusion between CCVs and 
EEs involves specific rabs, phosphatidylinositol kinases (PI-Ks),docking factors and v- 
and t-SNAREs. Rabs act as molecular switches, cycling between inactive GDP-bound 
and active GTP-bound states. These changes in activity are coupled to the reversible 
association with their target membranes156 and recruitment of PI-Ks and docking factors 
g, fission, vesicular (and tubular) trafficking and 
such as EEA1. The PI-Ks function to phosphorylate phosphatidylinositols creating 
docking sites for the various components of the fusion machinery157-159. EEA1 is a 
homodimer which binds via FYVE domains to PtdIns(3)P, and also to Rab5, on EE and 
functions as a docking factor for incoming vesicles160, facilitating the interaction between 
t-SNARES (on target membranes) and v-SNARES (on docking membranes)159, and the 
consequent fusion of vesicles with target compartments161. 
In EE cargo is selected for transport onwards to late endosomes and lysosomes or 
recycling back to the cell surface. The various other compartments within a cell are 
likewise interconnected through buddin
fusion events, and the specific factors governing these events at specific locations differ, 
providing the necessary heterogeneity of the system156,157,162. 
Adding another layer of complexity to the endosomal system is the generation of intra-
lumenal vesicles and, as MHC class II is intimately involved with these, it warrants a 
brief mention. Multi-vesicularity exists in varying degrees throughout the degradation 
pathway from EE, through late endosomes (LE) to lysosomes. Ubiquitinilation of the 
cytoplasmic domain of transmembrane proteins is the best described mechanism for 
sorting into MVBs.  ‘Hepatocyte-growth-factor-regulated tyrosine-kinase substrate’ (Hrs) 
recruitment to membranes is dependent on PI3K activity163, it recruits clathrin through a 
direct interaction164 and binds to ubiquitin through its ubiquitin-interacting motif165. Hrs 
recruits ‘endosomal sorting complex required for transport’ (ESCRT)–I to endosomal 
membranes, and the sequential action of ESCRT-I, -II and –III is required for sorting into 
and formation of intralumenal vesicles166. The specific mechanism for sorting of MHC 





2.2 MHC class II and Ii in the endocytic pathway 
 
There has been some debate concerning the entry-point of the (αβIi)3 complexes into the 
endocytic pathway from the trans-golgi network (TGN), and two main pathways have 
been described. The first postulates a direct transport from the TGN to a class II loading 
compartment (late endosome/lysosome related organelle)167,168, whilst the second  
 
Figure 8. MHC class II/Ii transport route. Obtained from Gregers et al. Intracellular Pathogens in Membrane Interactions and 
Vacuole Biogenesis (2003). 1) The (αβIi)3 complex is transported to the plasma membrane where (2) it is rapidly internalized, and 
targeted to early endosomes (3) where degradation of Ii begins. The complex is then transported to later endocytic compartments 
with higher proteolytic activity (4). MHC class II-CLIP associates with HLA-DM, which has been transported directly from ER 
(5) HLA-DM replaces CLIP with peptides and a  conformational change in the MHC class II-peptide complex induces the 
transport towards (6) and release to the cell surface (7). Mature peptide-MHC class II complexes can recycle at the plasma 
membrane (8, 9). A minor fraction of MHC class II-Ii complexes may be transported directly to early endosomes (10). Ii is 
produced in excess of class II molecules, and may be released from ER in the absence of class II (11). These Ii molecules may 
interact with mature MHC class II molecules at the plasma membrane (12) and thereby target MHC class II to late endosomes or 
PLC for new rounds of peptide loading (13). See text for details. 
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describes an indirect transport via the PM169-171, a third possibility is that transport may 
occur by both pathways (Figure 8). The cytoplasmic tail of Ii contains two leucine based 
signals (3DQRDLI8 and 12EQLPML17)51,172,173. Both signals are independently sufficient 
for lysosomal localization of Ii, but L7I8 is a more potent endocytosis motif174. Ii has been 






proteas es are required190. The first step 
in Ii processing is the removal of the C-terminal domain. If cysteine proteases are 
endosomes)175 and AP-2 µ-subunits via its di-leucine based signals63,146. Recent studies 
using RNA interference against constitutive subunits of the adaptor complexes indicates 
that the major (αβIi)3 pathway is via the plasma membrane as depletion of AP-2 lead to a 
large increase in surface (αβIi)3 whereas depletion of AP-1/-3/-4 had little or no 
effect176,177. Several earlier studies using dominant negative dynamin (K44A)178 or
clathrin179, selective inactivation of EE180 and AP-3 deficient cells181,182 have provided 
similar results. Other mechanisms for sorting from the TGN exist however183. ‘Golgi-
localized/γ ear-containing/ADP-ribosylation factor-binding’ (GGA) proteins bind to 
motifs that contain a cluster of acidic residues followed by a di-leucine signal184,185. Such 
a cluster is present before the 3DQRDLI8 motif in the cytoplasmic tail of Ii, however, 
experiments performed in our lab show that the different GGAs do not interact with this 
motif (C. Fladeby et al. unpublished data). At the PM (αβIi)3 is rapidly internalized169,186 
and traffics through early endosomes to late endosomes and lysosomes. Along this 
pathway MHC class II is gradually transferred to intra-lumenal vesicles, and Ii is 
processed to allow peptides access to the peptide binding groove.   
 
2.3 Ii processing and proteases in endosomal compartments 
 
During the passage through the degradation pathway Ii and internalized antigen are 
sequentially degraded by an array of specific and non-specific proteases (Figure 9). This 
processing and the proteases responsible are essential components in MHC class I
ntigen presentation, and have been extensively studied (reviewed in references187-189).
owever, as there are multiple enzymes present in the class II/antigen pathway, with
road and sometimes overlapping specificities, the question remains whether the generic
e activity is sufficient or whether specific enzym
 21
Figure 9. Invariant chain processing. Obtained from Watts, Nat Immunol (2004). Intermediates in processing include p22, p10 
and CLIP. DM releases CLIP and, with reduced efficiency, catalyzes release of the p10 intermediate as well. Intramembrane 




inhibited using leupeptin, a 22 kDa fragment of Ii accumulates191,192 (p22), the enzyme 
responsible for the initial cleavage under these conditions has been identified as 
asparagine endopeptidase (AEP). AEP targets N155 and possibly N132 in the lumenal 
portion of Ii193. Cysteine proteases remove the lumenal trimerization domain generating 
the 18 kDa and 10 kDa Ii products (p18 and p10 respectively). p22, p18 and p10 all 
maintain the nonameric structure (and class II interaction)192,194 through interactions 
ithin the TM segment. The next step in Ii processing has been attributed to cathepsin S 
ent195 and delayed 
rt of at least some MHC class II haplotypes . Other enzymes may however 
198 199 200
w
and inhibition of this enzyme leads to accumulation of the p10 fragm
196,197transpo
substitute for cathepsin S, and cathepsin L , cathepsin V  and cathepsin F  have all 
been shown to process p10 in cells lacking this enzyme. Processing of p10 leaves only 
CLIP bound to the peptide binding groove of MHC class II, and removal of this is 
catalyzed by HLA-DM. A final cleavage event may however take place. As shown for 
murine B cells, an intra-membrane cleavage event (at residues 42-44) releases the 
cytosolic portion of Ii and this may initiate a signaling cascade resulting in the activation 
of NF-κB and transcription of target genes65. 
The presence and activity of certain specific proteases is critically important for the 
optimal generation of some T cell epitopes, whereas other epitopes are susceptible to 
destructive processing and require the inactivity of certain proteases. Yet other epitopes 
again may have less specific processing requirements. As previously mentioned, the 
endocytic pathway becomes gradually more acidic the deeper into it an antigen 
progresses, and this in itself contributes to regulate the activity of some pH dependent 
enzymes. Adding to this, certain proteases are specifically regulated at the transcriptional 
level and also by activating- and inhibiting factors. Interestingly the p41 isoform of Ii is 





idered a one-way street (with the obvious 
, th
skeleton an
4 Retrograde transport of MHC class II molecules 
The endocytic pathway has generally been cons
exception of the sorting compartments/early endosomes/recycling endosomes) whereby if 
a molecule passes the point of no return, it cannot escape the finality of degradation in 
lysosomes at the journeys end. However for some molecules, such as CD63204 and MHC 
class II205-207 is does not seem to be the case. The retrograde pathway for class II 
molecules initially requires the translocation from the inner to the outer membranes of the 
peptide loading compartments, the mechanisms involved in these “back-fusion” events 
are however as yet unresolved208. After transfer to the limiting membrane, MHC class II 
is transported to the cell surface. Also here the machinery involved remains elusive, but it 
seems that the transport may occur both by carrier vesicles209,210 and tubular 
extensions205,206,211. Both routes are dependent on the cyto d motor-proteins, 
and this would require specific adaptors for attachment, tetraspanins could possibly be 
involved. An alternative retrograde pathway for MHC class II is the fusion of the limiting 
membrane of peptide loading compartments with the PM and consequent release of class 
II containing vesicles, exosomes212. These secreted particles are able to activate naïve T 
cells and have been used successfully for in vivo immunization for anti-tumor 
immunity213. 
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Retrograde transport of MHC class II in DCs represents a particular paradigm. As 
mentioned initially, imDCs retain their class II molecules largely internally, whereas after 
exposure to pathogenic agents or inflammatory stimuli, they up-regulate surface 
expression of class II (and co-stimulatory molecules). This clearly involves a tight 
regulation of class II transport, and several mechanisms have been proposed. These 
include regulating assembly of stable class II-peptide complexes by reduced degradation 
of Ii (regulating protease activity)2,214 and modulation of endocytic activity (regulating 
small GTPases, these studies imply a somewhat different transport pattern with no 
retrograde transport from lysosomes involved)5,215. Adding to this, a recent study has 
shown that an elevated expression of Ii, as has been reported in imDCs23, may by itself 
ause the redistribution of mature, as well as newly synthesized class II, to loading 
ffectively regulate class II 
lasma membrane expression (Landsverk et al. Manuscript), . It seems likely however, 
may partition into specific membrane micro-domains (lipid rafts) at the cell 
surface218, and this has been suggested to be of vital importance for activation of naïve T 
c
compartments indicating that controlling Ii synthesis will e
p
that several mechanisms will be operating in parallel. 
 
2.5 MHC class II and Ii at the plasma membrane 
 
MHC class II may be found at the cell surface in at least two distinct forms. As 
mentioned above, newly synthesized (αβIi)3 complexes are transiently exposed at the PM 
en route to loading compartments, these are however, rapidly internalized and contribute 
little to the PM expression. In contrast mature, peptide loaded MHC class II may reside 
stably at the cell surface for several days after activation with pathogenic-/innflammatory 
stimuli216. These molecules may however be internalized to recycling compartments, 
where they may load or exchange peptides9, before returning to the cell surface. This 
internalization is independent on Ii, it is instead mediated by a leucine-based signal 
located in the MHC class II β chain (LL in mice47 and a corresponding FL in humans217). 
However, it has recently been shown that these mature class II molecules are also 
susceptible to the effect of free-Ii transiting the cell surface, and may be redirected also to 
more acidic compartments (Landsverk et al. Manuscript). 
MHC class II 
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cells219. The association with these lipid rafts may occur before antigen loading and has 
been proposed to facilitate the enrichment of specific peptide-MHC combinations in 
these membrane microdomains220,221. The existence of lipid rafts is, however, somewhat 
controversial. Their existence is largely based on the observation that a significant 
fraction of the membrane is detergent insoluble, and the composition of the isolated rafts 
is markedly dependent on the conditions used for their preparation222,223. Studies using 
advanced microscopy techniques have so far produced inconclusive and/or contradictory 
results223-225, but a recent report indicates that they are not involved in the organization 
and signalling from the TcR226. Lipid raft partitioning has also been implicated in 
signaling from class II molecules227, and disruption of raft association by methyl-β-cyclo-
dextrin results in inhibition of class II mediated activation of protein tyrosine kinases 
(PTKs), and cell-cell adhesion218, but not ERK1/2 activation218. Signaling from class II 
molecules can trigger various signaling pathways and regulate numerous APC activities 
such as cytokine production, maturation and apoptosis. Ligation and (in some cases) 
imerization can result in Src family PTK activation (cytokine production), protein 
itogen-activated protein kinase 
APK) cascades (reviewed by Al-Daccak228). Signaling from class II molecules may 
d
kinase C (PKC) activation (apoptosis) and activation of m
(M
also be involved in regulating class II transport, and Boes et al. have shown that after an 
initial encounter with T cells, DCs extend MHC class II dense tubules toward the T cell-
DC interface205. Tetraspanins have also been implicated in organizing class II and 
accessory molecules in specific membrane micro-domains. Interestingly, these domains 
were found to be highly enriched in specific peptide-MHC combinations, and their 
disruption severely impaired T cell activation229. The successful activation of a naïve T 
cell may require as few as 10 specific MHC class II-peptide combinations230. This 
represents less than 0,1% of the total amount of class II on an APC surface, and 
considering the number of peptide-MHC combinations present, a mechanism for 






Aims of the project 
 
The influence of Invariant cha n the traffic of MHC class II molecules is, in the 
textbooks and current reviews, restricted to the initial transport of newly synthesized 
MHC class II to from ER to the peptide loading compartments. However, the elevated 
expression of Ii compared to class II has prompted two groups to suggest a potential post 
ER interaction between MHC class II and Ii. In 1995 Henne et al. proposed that free-Ii 
could associate with empty class II molecules at the PM and promote their endocytosis 
and delivery to loading compartments
in o
)3
 induced Ii. Molecular 
loning techniques were used to generate chimeric proteins and deletion mutants. 
iochemical methods were applied to obtain quantitative data, and scanning laser 
onfocal microscopy to visualize protein trafficking in real-time. 
231, and this was later elaborated on by 
Moldenhauer et al.231. In 1999 Triantafilou et al.232,233 detected (αβIi)3 complexes at the 
cell surface in their studies and came with a similar proposition. However, these studies 
were not able to distinguish between newly synthesized (αβIi  complexes assembled in 
the ER and free-Ii associating with class II at later time points. The post-ER interaction 
therefore remained highly hypothetical, and has not been implicated in MHC class II 
trafficking. With the rapid development of new life-sciences tools it has now become 
possible to distinguish between the two. This study was set up to solve this question. 
 
The aims of the study: 
 
a) Definitively establish a post-ER interaction between Ii and MHC class II 
b) Examine the consequences of this interaction on MHC class II distribution 
c) Determine the domains of Ii required for plasma membrane clearance of class II 
 
To address these questions we utilized a photoactivable green fluorescent protein 
(PAGFP), fused to MHC class II, in combination with an inducible expression system for 
Ii. This allowed us to specifically image the fraction of class II available at photo-








3.0 The photoactivable green fluorescent protein 
 
The photoactivable green fluorescent protein (PAGFP) was initially presented by 
Patterson and Lippincott-Schwartz in science 2002234, it is a derivative of wtGFP that 
remains ‘in-excitable’ to the 488 nm laser until ‘photo-converted’ with a 405 nm laser 
(Figure 10). This makes it a convenient tool for imaging a sub-population, in time or 
space, of ‘PAGFP-tagged’ molecules235.  
Studies by other groups have previously used fluorescent proteins attached to the human 
or mouse MHC class II β chain103,205,236 and we attempted to do the same with PAGFP. 
We constructed fusion proteins using two different HLA-DRβ alleles with various linker 
sequences. However, all fusion constructs were retained in the ER, whereas the EGFP 
constructs made in parallel trafficked normally. 
PAGFP is in sequence similar to wtGFP, the only difference between the two is a 
threonine to histidine substitution in the 203 position (T203H). The enhanced GFP  
 
ectrum is represented by the solid 
trum in open squares. 
Figure 10. wtGFP β-barrel and PAGFP exitation/emission spectra and photoactivation. a) Adapted from Van Thor et al. (2001) 
and b) obtained from Patterson and Lippincott-Schwartz, Methods (2004). a) Wild type GFP β-barrel. The replaced threonine 
indicated by arrow. b) PAGFP absorbance and emission spectra. Native PA-GFP absorbance sp
circles. Photoactivated PAGFP absorbance spectrum is shown in open circles and emission spec
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(EGFP) is slightly further removed from PAGFP, with an additional serine to threonine 
bstitution in position 65 (S65T). This small difference is however enough to abolish the 
rendering our fusion constructs 
capable of export from the ER, comes on the outer surface of the GFP beta barrel 
 and trans-activates MT gene expression 
ter239. 
Transfected into MDCK cells hMTIIA is effectively activated by addition of cadmium
indicating that also the canine MTF-1 is of high homology. 
 
in  
with the MHC class II/Ii transport as a consequence of these endogenous genes being 
su
effect of the T203H mutation. The T203H substitution, 
in
(Figure 10), presumably causing some minor conformational change in GFP. This might 
interfere with the proper dimerization of the α and β chains, and consequent sequestration 
in the ER. However, attaching PAGFP to the α chain of the heterodimer, resulted in 
proper dimerization and consequent transport out of the ER.  
 
3.1 The metallothionein inducible invariant chain 
 
The pMEP4 vector from Invitrogen contains the human metallothionein (MT) promoter 
hMTIIA237. The Metal response element-binding transcription factor-1(MTF-1) binds 
specifically to metal response elements (MREs)
in response to zinc and cadmium238. MTF-1 is highly conserved in evolution, mouse and 
human MTF-1 are 93% similar, and mouse MTF-1 can activate the human promo
, 
The inducible expression system containing the metallothionein promoter has the major 
advantage of being fast and easy to use. As opposed to other transfection systems it 
requires only one transfection, and not the multiple rounds needed in other systems. It is 
however, somewhat prone to leakage, with a varying degree of low basal Ii expression. 
This does not constitute a direct problem in the study presented. We have all the same 
constantly compared our results with un-induced cells and cells that are induced but 
lacking Ii (see for instance figure 2B in manuscript). A very high basal level would of 
course be detrimental to our studies, and although this is very rarely the case, most 
imaging was conducted with the monoclonal anti-Ii antibody BU45 conjugated to alexa 
546 in the medium. This has the additional benefit of verifying a high Ii expression as 
cause for the observed effect. Cadmium will also turn on a set of metallothionein
ducible genes240. However, in the study presented here, we could detect no interference
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turned on. The trafficking and interactions observed were the same in the absence of 
CdCl2. Cadmium is cytotoxic to cells if administered in high doses. Titration studies have 
previously been carried out in our lab to assess growth inhibition under varying doses. 
We have on the basis of these used 15-25µM CdCl2 in the experiments, this dosage 
provides adequate induction without detectable growth inhibition. 
 
3.2 Cross-species considerations 
 
In the presented study we have, mostly in parallel, used both human and murine class II 
he murine and human Ii are 
owever, highly homologous (76.2% identical/85.1% positives)1 and mouse I-Ak 
al trafficking machinery, is 
molecules, in combination with exclusively human Ii. T
h
effectively co-immunoprecipitates human Ii241,242.  I-Ak and HLA-DR1 are structurally 
similar, display large sequence homology (52.3%/64.5% for α, 61.8%/70% for β)1 and 
almost identical organization of the conserved domains and sequences2. It has been 
previously shown that transport and function proceeds similarly with both combinations 
(HLA-DR/Ii or I-Ak/Ii)243. Another aspect that must be considered is the use of human Ii 
in a canine cell line. As for mouse Ii, the predicted canine Ii3 is highly similar to human. 
The N-terminal region, which interacts with the essenti
aligned with human Ii in figure 11. As indicated, the charge distribution and sorting 
signals are conserved, implying that the interactions described above apply also in this 
species. 
 
                                                 
1 Calculated using alignX, mouse Ii (P04233)/human Ii (P04233-N-terminal extension), H-2Akα (P01910)/ 
HLA-DR1α (P01903), H-2Akβ (P06343)/HLA-DR1β (P04229) 
2 Determined by an  domain architecture of sequences above in Vector NTI, and their 3 dimensional 
structures (I-Ak by Fremont et al 1997, HLA-DR1 by Zavala-Ruiz et al. 2003) 
3
alysis of
 LOC479329 on chromosome 4 
Figure 11. Comparizon of human and canine Ii N-terminal sequences. Sequences acquired from NCBI, (accession numbers 
indicated) and aligned using alignX, VNTI (InforMax, Invitrogen). 
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3.3 Cell lines 
 
MelJuSo is a human melanoma cell line that expresses endogenous HLA-DR3. It was 
used in this study to examine the various HLA-DRPAGFP constructs. Single MHC class II 
α or β chains are retained in the ER, and the same applies to the early HLA-DRPAGFP 
onstructs, it was therefore convenient to use a cell line that expressed both α and β and 
port the constructs to the plasma membrane. 
adin Darby canine kidney (MDCK) cells are from a female cocker spaniel244. There are 
PAGFP is ideally suited to our approach as it is entirely invisible before activation
 
therefore generated cell-lines expressing HLA-DR1α-PAGFP and HLA-DR3β with or 
but non-homologous 
c
would assemble heterodimers and trans
M
two variants, MDCK I and MDCK II, the latter being the original strain and the one used 
in the study presented here. MDCK cells are easy to grow, highly resilient and easily 
manipulated, they form polarized mono-layers on almost any substrate making them 
convenient for microscopy studies. When confluent, MDCK cells sort their class II 
molecules to the basolateral side and as their tight-junctions are close to the apical face, 
this makes it easy to get a nice confocal slice with clear cell surface fluorescence. 
M1 is a human fibroblast cell line derived from the SV40-transformed xeroderma 
pigmentosum cell line SV40XP12RO245. It was used for some of the immuno-
fluorescence microscopy mentioned in the manuscript, but is reportedly highly sensitive 
to ultraviolet light, which makes it an unsuitable recipient for PAGFP. 
 
3.4 Stable transfection 
 
 
(Figure 12). This however, makes it impossible to detect positive cells without activating 
them, and time consuming to find transfected cells when doing transient transfections. 
Added to this there is the requirement for the cells not only to be expressing HLA-DR1α-
PAGFP, but also HLA-DR3β and the inducible Ii. All together this makes it difficult, if 
not impossible, to conduct these experiments on transiently transfected cells. We
without Ii. Stably transfected cells are not, however, as stable as the given term implies, 
and individual cells within the population are prone to discard one or two, or all 
onstructs. The reason for this is not well understood, c
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recombination usually results in the insertion of multiple copies of the transfected 
onstruct(s) (tandem repeats). It is therefore likely that during mitosis there will be a high c
frequency of crossing over and consequent ‘breakage-fusion-bridge’ cycles246, which 
may eventually lead to expulsion of the transfected sequences from the genome. The 
frequency of these events seems to increase with the number of constructs inserted, which 
is not surprising considering the similarity of carrier vectors, consequently what started as 
the ‘perfect’ cell line may degenerate into something rather less ideal.  
 
Figure 12. Photoactivation. Left half of micrograph photoactivated (405 nm laser at 40%) in the upper sequence, right half in the 
lower sequence. Cells are MDCKIi+βαPA imaged with 488 nm at 6%, 543 nm at 2% (lysotracker-red), 320x320 pixels, 1.4xZoom, 
60/1.1 oil immersion objective, on an Olympus FV1000 scanning laser confocal microscope. 
 
 
3.5 Live scanning laser confocal imaging 
 
The Olympus FV1000 confocal scanning laser m
the PAGFP. With its real-tim
icroscope is the perfect companion to 
e bleach capacity it is possible to photoactivate and image at 
e time (Figure 12). This is highly convenient for assessing amount of 405nm laser the sam
needed for activation as too much laser will bleach the fluorescent probes. The sequential 
line-by-line excitation/acquisition minimizes ‘bleed-through’ and provides reliable 
fluorochrome localization/colocalization. PAGFP emits significantly less light than 
EGFP under the same conditions (laser intensity), thus it requires more laser, a higher 
expression level or more enhancement of the signal. Higher laser intensity is unfortunate 
as it will bleach the sample, it may also cause damage to the cells (photocytoxity). A very 
high expression level is not desirable as it might cause stress and other bi-effects in the 
cells. Enhancing the signal increases the noise to signal ratio, making the images less 
clear. We have chosen to image cells with an intermediate PAGFP expression level with 
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a slightly higher 488 nm laser intensity (3-9%), and an intermediate to high noise to 
signal ratio. Transmission light images were obtained throughout the experiments to 
verify that the cells remained healthy. This allows us to obtain the required information, 
the images, however, are not always of the highest resolution. As mentioned above, 
stably transfected cells have a tendency to expel one or more of the constructs, and 
consequently we have imaged at low zoom to observe many cells and used internalization 
of BU45 as an Ii-expression positive marker. All live-imaging experiments have been 
repeated at least three times, the results in the manuscript and supplementary movies are
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Abstract. The major histocompatibility (MHC) 
class II molecules present peptides to the T 
cell receptor on CD4+ lymphocytes. The 
diversity of the epitopes presented depends 
critically on the processing of the ingested 
antigens, and the endocytic pathway 
constitutes a set of increasingly protease-
rich/acidic compartments to facilitate the 
progressive digestion of antigens. Targeting of 
newly synthesized MHC class II molecules to 
more acidic endosomal compartments 
depends on association with the invariant 
chain (Ii) molecule. Ii is synthesized in excess 
of class II and is also present in a MHC class 
II-free form. It is therefore possible that Ii may 
have other functions in post-endoplasmatic 
reticulum compartments. In this study we 
demonstrate the interaction between free Ii 
and mature MHC class II molecules present at 
the plasma membrane. Using a 
photoactivatable green fluorescent protein 
(PAGFP) fused to MHC class II in combination 
with an inducible expression system for Ii we 
show that excessive amounts of Ii causes an 
increased endocytosis of mature class II, and 
the redistribution of these to late endosomes 
and lysosomes. This secondary association 
will thereby expand the repertoire of peptides 







The MHC class II molecules are expressed as 
heterodimers of two transmembrane polypeptides. 
The α (35kD) and β (27kD) chains spontaneously 
associate in the endoplasmatic reticulum (ER)1 via 
interactions between their transmembrane and 
lumenal domains. Correctly assembled heterodimers 
may traffic through the ER and Golgi apparatus to the 
plasma membrane. At the cell surface they may enter 
early endosomal compartments and load peptides for 
presentation to CD4+ T lymphocytes. Correct 
assembly and transport of MHC class II is, however, 
greatly enhanced in the presence of Ii (Cresswell, 
1994). Ii is a type II transmembrane glycoprotein that 
exists in different isoforms due to alternative splicing 
and use of alternative translation initiation start sites 
(Strubin et al., 1986; O'Sullivan et al., 1987). In the 
ER, Ii forms trimers which associate with three class 
II heterodimers forming a nonameric class II-Ii 
complex (αβIi)3.  
The association is driven by several class II–Ii 
interacting domains, with the most prominent being 
the class II interacting invariant chain peptide (CLIP) 
(Freisewinkel et al., 1993; Romagnoli and Germain, 
1994). CLIP binds in the peptide binding grove of 
class II, stabilizing the heterodimer (Anderson and 
Miller, 1992), and preventing premature peptide 
binding (Roche and Cresswell, 1990; Busch et al., 
1996).  
Two leucine-based sorting signals in the Ii 
cytoplasmic tail (Pieters et al., 1993; Bremnes et al., 
1994; Odorizzi et al., 1994) target the (αβIi)3 complex 
to the endosomal/lysosomal system  where Ii is 
sequentially degraded from the lumenal side (Watts, 
2001), leaving only CLIP bound to the peptide 
binding grove of the αβ heterodimer. Exchange of 
CLIP for antigenic peptide is facilitated by the 
catalytic action of HLA-DM, which acts as a peptide 
editor, promoting the loading of tightly binding 
peptides (Brocke et al., 2002). Peptide loading onto 
MHC class II molecules has been found to take place 
throughout the endocytic pathway, although several 
characteristics have been defined for the 
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The MHC class II heterodimer also contains signals 
for endosomal sorting (Salamero et al., 1990; 
Simonsen et al., 1993; Humbert et al., 1993) and can 
be internalized and recycled in the absence of Ii. Pinet 
et al. (Pinet et al., 1995) have shown that the 
cytoplasmic tails of the αβ heterodimers are essential 
for this routing, Zhong et al. (Zhong et al., 1997) 
reported that the LL sequence in the C-terminus of the 
murine β chain is a sorting signal, and the HLA-DRβ 
chain was confirmed to contain a corresponding 
signal (Simonsen et al., 1999). Cells expressing class 
II molecules in the absence of Ii can present certain 
exogenous peptides efficiently (Miller and Germain, 
1986; Sekaly et al., 1986; Anderson et al., 1993; 
Nijenhuis et al., 1994; Pinet et al., 1995), 
demonstrating that recycling class II molecules can  
reach endosomes containing degraded antigens. 
Recycling class II molecules, however, preferentially  
bind peptides in early endosomes (Pinet and Long, 
1998), whilst newly synthesized MHC class II 
molecules bind peptides in later compartments 
(Zhong et al., 1997). The endocytic pathway exposes 
internalized antigens to a progressively lower pH and 
to higher concentrations of proteases (Trombetta and 
Mellman, 2005). Newly synthesized and recycled 
MHC class II molecules would therefore be expected 
to present different peptides (Pinet et al., 1995; Zhong 
et al., 1997). It is, however, still unclear whether 
mature class II molecules that recycle at the plasma 
membrane may reach more acidic compartments, or if 
they are restricted to early ‘recycling’ endosomes. 
The class II associated invariant chain is in antigen 
presenting cells (APCs) produced in excess of MHC 
class II α and β chains (Machamer and Cresswell, 
1982; Kvist et al., 1982; Nguyen and Humphreys, 
1989; Kampgen et al., 1991). It has previously been 
shown that the free pool of Ii can modulate antigen 
processing and presentation by reducing degradation 
of antigen and Ii itself (Gorvel et al., 1995; Gregers et 
al., 2003). MHC class II associated- and free Ii 
follows the same pathway to late 
endosomes/lysosomes, mainly (Roche et al., 1993; 
Hansen et al., 1996; Wang et al., 1997), if not 
exclusively (Dugast et al., 2005; McCormick et al., 
2005), via the plasma membrane. At the cell surface 
they are rapidly internalized, with a half-life of 1-5 
minutes (Bakke and Dobberstein, 1990; Roche et al., 
1993; Bremnes et al., 1994), due to the strong 
internalization signal in the cytoplasmic tail of Ii 
(Kang et al., 1998). A secondary ‘post-ER’ interaction 
between free-Ii and mature class II could provide the 
mechanism for sorting mature class II deeper into the 
endocytic pathway. The intimate relationship of Ii 
with newly synthesized class II has however, made it 
difficult to separate the primary interaction in the ER 
and a potential secondary post-ER interaction. In this 
study we have taken advantage of the 
PAGFPc(Patterson and Lippincott-Schwartz, 2002), 
and fusion of this to MHC class II has enabled us to 
show how an inducible invariant chain caused the 




In order to examine whether the free pool of Ii can 
affect the trafficking of mature MHC class II 
molecules, we utilized MDCK and/or M1 cells 
constitutively expressing mouse or human MHC class 
II, I-Ak and HLA-DR respectively, and Ii p33 under 
control of a metallothionein promoter. I-Ak has 
previously been shown to associate with human Ii 
(Simonsen et al., 1993) and Ii p33 is the major Ii 
isoform expressed in APCs (Strubin et al., 1986; 
O'Sullivan et al., 1987). Most of the results presented 
in this study were done in parallel using both cell 
types and both human and mouse MHC class II, 
where otherwise the cell- and class II-type is 
indicated. Ii constructs used in this study are listed in 
Figure 1. 
To initially establish the effect of saturating amounts 
of Ii, we performed an over-night incubation with 
CdCl2. We found that increasing expression levels of 
Ii redistributes MHC class II from the plasma 
membrane to intracellular compartments. To assess 
the relative time-frame of this redistribution, we fixed 
the cells at different time points after Ii induction. 
This revealed that after 4 hours, there was a marked 
decrease of MHC class II at the cell surface and after 
6 hours it was mainly localized to intracellular 
compartments (unpublished data, but Figure 3A 
contains similar results). The sorting signals in the 
cytoplasmic tail of Ii have been shown to affect 
various transport steps from the ER to the endocytic 
pathway. To confirm that the depletion of class II 
from the plasma membrane was dependent on the 
endosomal sorting function of Ii, we performed the 




Figure 1 Ii constructs used in the study. Ii D6R was 
created by site-directed mutagenesis on the cytoplasmic tail of 
Ii. Ii HA has a sequence derived from hemagglutinine in place 
of CLIP and was generated by PCR-soeing. The TfR-Ii fusion 
protein consists of the cytoplasmic tail and transmembrane 
domains from human Ii (p33) and the lumenal domain of the 
transferrin receptor. The C-terminal deletion mutants were 
generated by PCR (using pSV51L-Ii as a template). All 






cytoplasmic tail (Ii∆20)(Bakke and Dobberstein, 1990). 
MHC class II remained at the plasma membrane, even 
after 6 hours, where it colocalized with Ii∆20, showing 
that the internalization was dependent on intact 








ated MHC class II are redistributed from
 hours hardly 
To quantify the observed Ii mediated redistribution of 
MHC class II we incubated MDCKI-Ak/Ii-wt cells with 
iodinated anti-I-Ak antibodies at different time-points 
 after Ii induction (Figure 2). We found that after 3 
hours of induction, I-Ak was still predominately 
expressed at the plasma membrane whilst after 4 
hours surface labeling had decreased by 45%. After 
15 hours of Ii induction, only 25% of total MHC class 
II was found at the cell surface. These results show 
that between 3 and 4 hours Ii causes a significant 
reduction of class II at the plasma membrane. 
However, newly synthesized MHC class II would be 
expected to contribute to the total amount of cell 
surface class II and to investigate this contribution we 
a
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ttached PAGFP to the c-terminus of the HLA-DR α-
hain and generated MDCK cells stably expressing 
LA-DRPAGFP and inducible Ii. By photoactivating 
lass II and inducing Ii after 1 hour (to allow egress of 
he now fluorescent MHC class II from the ER), we 
ere able to exclude imaging newly synthesized, Ii 
ssociated, class II. As shown in figure 3A, the
Figure 2 Quantification of Ii mediated class II 
redistribution. MDCKI-Ak/Ii-wt cells were incubated with 
25µM CdCl2 for 0, 1, 3, 6 and 15 hours before they were 
placed on ice, washed in ice cold PBS and labeled with 
2µg/ml 125I-H116-32 for 45minutes. The cells were then 
washed extensively with PBS/BSA prior to acetic acid 
atment to collect the surface bound 125I-H116-32. The 





e plasma membrane to intracellular compartments, 
were they colocalize with Ii, eventually forming the 
characteristic Ii induced large endosomal vesicles 
(ILEVs). The time frame of the “take-down” was seen 
to increase dramatically after 3-4 hours, thus 
supporting our previous result. After 12




Figure 3 Distribution of photoactivated MHC class II with induction of Ii (A), without Ii (B) and with indused TfR-Ii (C).
MDCKIi+βαPA (A) and MDCKβαPA (B) were incubated with BU45 for 30 minutes and MHC class II was photoactivated with the 
405nm laser and allowed to exit the ER for 1 hour before 15µM CdCl2 was added to the medium to induce Ii expression (A) or 
observe unspecific bi-effects of Cd2+ (B). MDCKβαPA were transiently transfected with TfR-Ii, and transferrin-alexa647 and 
15µM CdCl2 was added to the medium 2 hours before imaging to detect TfR-Ii positive cells (C). MHC class II was 
photoactivated and imaged as above. Images obtained every 3 minutes, images from selected time points shown. 
 
 
surface.   
In cells not expressing Ii, but otherwise treated in the 
same manner, the labeled class II molecules remained 
at the cell surface for the duration of the experiment 
Ii contains within its cytoplasmic tail two stro
internalization motifs, both independently suffici
 (Figure 3B). This shows that it is indeed mature 
MHC class II that under the influence of Ii is 
internalized to endosomes.  
Ii has fusogenic properties, when over expressed in 
cells it causes the generation of enlarged endosomal 
vesicles (ILEVs) (Stang and Bakke, 1997). Thus, it 
could be speculated that these might capture recycling 
MHC class II molecules. To examine the contribution 
of such an effect, we transfected cells with an Ii 
mutant (IiD6R) that is unable to cause endosomal 
retention (Nordeng et al., 2002). We found that the 
class II redistribution from the plasma membrane to 
endosomes was the same as for Iiwt, indicating that the 
membrane capturing properties of Ii do not contribute 
to the effect. 
ng 
ent
tosis at the plasma membrane. It could
be speculated that the internalization was 
e 
R) and the intact 
s with CdCl2 for different time intervals, 





caused by the distribution of MHC class II to 
membrane domains involved in increased 
endocytosis. To investigate any such contribution, w
transfected the HLA-DRPAGFP cells with a chimeric 
protein containing the extracellular domain of the 
transferrin receptor (Tf
transmembrane and cytosolic domains of Ii (TfR-Ii) 
(Odorizzi et al., 1994). As shown in Figure 3C, the 
chimera was unable to deplete class II from the 
plasma membrane. This indicates that also the 
lumenal domain of Ii is required for the redistribution, 
and that the internalization is dependent on a specific 
interaction between Ii and mature class II.  
Newly synthesized MHC class II molecules are 
transported to late endosomes and lysosomes by Ii. 
To examine whether the internalized class II 





Figure 4 A) Ii transports MHC class II 
to late endosomes and lysosomes, B) 
The redistribution to LAMP1 positive 
compartments is independent of the 
sorting signals in MHC class II. 
MDCK
antibodies (Figure 4A). In the absence of Ii, class II 
was mainly localized to the plasma membrane, with a 
very minor fraction in LAMP1 positive 
compartments. After 4 and 6 hours, MHC class II was 
contribution by the sorting signal in the MHC class II 
cytoplasmic tails. 
Ii associates with the class II molecules via several 
nteracting domains, the most important be
depleted from the cell surface and the majority of 
MHC class II could be seen in LAMP1 positive 
compartments. Af





in cells with tailles
We found that HL
in the absence of 
was relocated to L




ing groove of the MHC
ction and consequent 
ter 15 hours of Ii induction MHC 
 almost exclusively in ILEVs where 
 LAMP1.  
d signal in the β chain mediates 
 recycling at the cell surface and to 
ution of this signal we expressed Ii 
s HLA-DR molecules (HLA-DR∆). 
A-DR∆ localized to the cell surface 
Ii, but after Ii induction HLA-DR∆ 
AMP1 positive compartments with 
HLA-DRwt (Figure 4B). This shows 
lization and trafficking to late 
mes is independent of 
i
CLIP region. The peptide bind  
class II present at the cell surface would however, for 
the majority of the class II molecules at least 
(Vacchino and McConnell, 2001), be occupied by 
peptides as empty class II are unstable (Rabinowitz et 
al., 1998), and prone to be sorted to lysosomes and 
degraded. It has been shown that the transmembrane 
domain of Ii contributes towards class II association 
(Castellino et al., 2001). However, the TfR-Ii chimera 
demonstrated that this domain was insufficient for a 
secondary ‘post-ER’ intera
plasma membrane clearance of MHC class II. To 
determine which regions of Ii N-terminal to CLIP are 
required to achieve MHC class II redistribution, we 
generated two Ii deletion mutants where the C-
terminal regions were removed, Ii1-90 and Ii1-80 (Figure 
1). The constructs were transfected into cells, but both 
Ii1-90 and Ii1-80 were retained in the ER, as observed by 
immunofluorescence microscopy  
I-Ak/Ii-wt (A) or MDCKHLA-DR∆/Ii-wt (B) 
were incubated with 25µM CdCl2 for 0, 
4, 6 and 15 hours and then fixed in 3% 
PFA. The cells were then labeled with 
the anti I-Ak antibody H116-32 (A) or the 
anti HLA-DR antibody L243 (B) and anti 
LAMP1 before labeling with secondary 
antibodies goat anti-mouse IgG 
Alexa594 (MHC class II) and goat anti-
rabbit IgG Alexa488 (LAMP1). Cells 





(unpublished data). We therefore decided to study the 
effect of CLIP and the other C-terminal parts of Ii 
separately, and to this effect we used a Ii construct in 
which CLIP was replaced with an irrelevant sequence 
derived from hemagglutinine (HA; YPYDVPDYA). 
This peptide is unlikely to associate with the peptide 
binding groove of I-Ak as it lacks the major anchor 
residues required for high affinity binding (Fremont et 
al., 1998). However, IiHA was still able to deplete I-Ak 
from the plasma membrane as observed by 
immunofluorescence microscopy (unpublished data). 
To obtain quantitative data on the effect of IiHA, 
MDCK cells were induced to express IiHA
rior to incubation with iodinated anti I-Ak antibodies 
n ice. Ii










 whether this region contributes to the 
ternalization of mature class II we made two new 
eletion mutants, Ii1-104 and Ii1-132 (Figure 1), which
HA was somewhat less efficient than Iiwt, but 
till able to cause internalization, indicating that 
ssociation via the CLIP region is not a prerequisite 
or cell surface clearance of MHC class II (Figure 5). 
hayer et al. (Thayer et al., 1999) have shown that a 
egion C-terminal to CLIP might interact outside of 
he peptide binding groove under conditions where 




we transfected into cells. Both mutants colocalized 
with class II in endosomes, indicating that they 
exhibited normal trafficking, and both were able to 
redistribute class II within 6 hours, as observed by 
immunofluorescence microscopy, although Ii1-104 
appeared less efficient compared to Iiwt and Ii1-132 
(unpublished data). Quantification of surface I-Ak 







caused increased internalization of  I-Ak, although 
somewhat less than Iiwt (Figure 5). Thus neither CLIP 
nor amino acids 105-216 are an absolute requirement 
for internalization of MHC class II. CD4+ T cells 
recognize antigenic peptides in the context of MHC 
class II and to further confirm that the amount of class 
II at the plasma membrane is reduced upon Ii 
expression, MDCKI-AK/Ii-wt cells were induced to 
express Ii for 2, 6 and 24 hours and consequently 
fixed in PFA. The cells were then incubated with 
synthetic HEL 116-129 peptide and the 1B9 T cell 
hybridoma. IL-2 production from 1B9 was measured 
indirectly by proliferation of the IL-2 dependant 
CTLL-2 cell line. As shown in figure 6, absence of Ii 










sent a general consensus that at least
ed at T=0 is set to 
16-129 epitope, whilst after 6 and 24 hours of Ii 
xpression activation of 1B9 T cells was reduced. 
his then supports our previous results, showing that 
i relocates MHC class II from the cell surface to 
ntracellular compartments resulting in reduced 
mounts of surface class II and less efficient 
resentation of the HEL 116-129 peptide to HEL 
pecific T cells. 
There is at pre
the vast majority of newly synthesized (αβIi)3 
complexes are transported via the plasma membrane 
to compartments where peptide loading can occur 
(Roche et al., 1993; Hansen et al., 1996; Wang et al., 
1997; Dugast et al., 2005; McCormick et al., 2005). 
At the cell surface both free Ii and (αβIi)3 complexes 
Figure 5. Quantification of Ii-mutant mediated class II 
redistribution. A) Ii C-terminal deletion mutants were 
created by PCR, subcloned into pMEP4 and transfected into 
MDCK I-Ak cells. B) Cells expressing Iiwt, IiHA, Ii1-104 and 
Ii1-132 were incubated with 25µM CdCl2 for 0 and 6 hours 
and then washed and incubated on ice with 125I-H116-32 
for 45 minutes. The cells were then washed extensively with 
PBS/BSA prior to acetic acid treatment to collect the surface 
bound 125I-H116-32. The acid wash was collected and 
counted in a COBRA γ counter. The results are given as 
mean duplicates were the value receiv
100%  
Figure 6 Ii mediated depletion of MHC class II results in 
less efficient activation of naïve T cells. MDCKI-Ak/Ii-wt 
cells were incubated with 25µM CdCl2 for 0, 6 and 24 hours 
to induce Ii expression before they were fixed in 1% PFA 
and incubated with 10µg/ml synthetic HEL 116-129 peptides 
and 5x104 1B9 T cell hybridomas over night. IL-2 
production from the 1B9 cells was measured indirectly by 
proliferation of the IL-2 dependent cell line CTLL-2. The 
results are obtained from one experiment done in triplicates.
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are rapidly internalized, whereas MHC class II 
unassociated with Ii may reside stably at the plasma 
membrane for several days (Cella et al., 1997). MHC 
class II and Ii are under subtly different 
transcriptional regulation (Peijnenburg et al., 1999) 
and there are reports which may indicate that also 
their mRNA stability may be variably controlled(Shih 
et al., 1997; Kuchtey et al., 2003). The class II 
transactivator (CIITA) can by itself cause the 
upregulation of both Ii and class II (Steimle et al., 
1994). The general higher expression level of Ii 
would ensure that enough Ii is available for efficient 
assembly and transport of newly synthesized class II 
in the ER. However as Ii is transported to the plasma 
membrane and the endosomal pathway in the absence 
of class II, it is possible that it may be further 
volved in modulating MHC class II transport and 
e class II molecules at the cell 





surface may enter endosomal recycling 
compartments. These MHC class II molecules may 
exchange/load peptides, but are not exposed to the 
wide repertoire that newly synthesized, Ii associated, 
class II molecules encounter in later endosomal 
compartments. 
Henne (Henne et al., 1995) and later Moldenhauer 
(Moldenhauer et al., 1999) and Triantafilou 
(Triantafilou et al., 1999) speculated that free Ii could 
associate with empty αβ dimers and promote their 
endocytosis and delivery to processing compartments. 
However, as they were not convincingly 
differentiating between an association in the ER and 
at the plasma membrane in their studies, this model 
has not been implicated in MHC class II trafficking. 
In our system we are able to discriminate definitively 
between the two. By using a PAGFP-tagged MHC 
class II, and an inducible expression system for Ii, we 
are able to exclude imaging the newly synthesized 
(αβIi)3 complexes. This allows us to specifically 
image mature class II and the effect of increasing 
amounts of Ii on them. 
Data presented in this study show that free-Ii 
appearing at the plasma membrane can cause the 
endocytosis and transport of mature MHC class II to 
more acidic/protease rich compartments. Ii will 
therefore expand the array of peptides encountered by 
mature class II molecules. The redistribution is 
dependent on the intact cytoplasmic tail of Ii, and 
rapid, with a dramatic increase in the internalization 
rate 3 to 4 hours after Ii induction. This time most 
probably correlates to the time that Ii saturates 
available class II in the ER and appears in large 
numbers at the PM alone. Ii is itself rapidly 
internalized at the PM, and would be presumed to 
capture and internalize class II with similar kinetics. 
Elevated expression of Ii has been shown to induce 
endosomal retention (Romagnoli et al., 1993; Pieters 
et al., 1993; Gorvel et al., 1995; Stang and Bakke, 
1997), and the clearance of class II from the cell 
surface could be thought to be due to retention in the 
recycling compartment. This would prevent return of 
recycling MHC class II molecules to the cell surface. 
However, under these conditions we have previously 
shown that the recycling pathway is unaffected, at 
least for the TfR (Gregers et al., 2003). In addition, an 
Ii mutant (IiD6R) that 
retention (Nordeng et al., 2002) was still able to cause 
the redistribution of MHC class II. Ii harbors in its N-
terminal cytoplasmic tail two signals that mediate 
rapid endocytosis at the plasma membrane (Pieters et 
al., 1993; Bremnes et al., 1994; Odorizzi et al., 1994), 
and the decrease in class II at the cell surface could 
possibly be caused by a unspecific internalization 
caused by increased endocytosis. However a TfR-Ii 
chimera (Odorizzi et al., 1994) with Iis cytoplasmic 
tail does not deplete class II from the PM.  
The major class II-Ii interaction site is the CLIP 
region. However, for the majority of class II 
molecules present at the cell surface the peptide-
binding groove should be occupied (Vacchino an
McConnell, 2001). The interaction was therefore 
presumed to involve different domains of Ii, and to 
examine this several C-terminal Ii deletion mutants 
were made and analyzed by both immunofluorescence 
microscopy and quantitatively by 125I labeling. Both 
Ii1-104 and Ii1-132 were able to cause the internalization 
of MHC class II, but somewhat less efficiently than 
Iiwt. Nevertheless we could conclude that none of the 
residues contained within amino acids 105-216 are 
absolutely required for the internalization. An 
additional Ii mutant with a sequence derived from 
hemagglutinine replacing CLIP was also able to 
redistribute class II, although significantly less than 
Iiwt, suggesting that the CLIP region may contribute to 
the interaction. As it is unlikely that this interaction is 
via the peptide-binding groove of surface MHC class 
II, we speculate that CLIP might impose a particular 
conformation onto neighboring regions which 
promotes their interaction with the class II molecule. 
All in all we did not find that one specific domain of 
Ii was responsible for the internalization, 
that the various class II interacting domains of Ii 
contribute and sum up to the effect. Considering the 
diversity of MHC class II alleles, a number of 
interaction sites would better facilitate the general 
mechanism, ensuring that the wide array of MHC 
class II alleles would be susceptible to this secondary 
interaction with Ii. 
The mechanism we describe could serve at least 3 
possible functions. The most obvious is to ensure the 
presence of class II molecules throughout the 
endocytic pathway upon the initiation of an immune 
response. However, it is also tempting to speculate 
whether this ability of Ii might be a factor involved in 
clearance of self-peptide loaded MHC class II after 
initiation of an immune response. The transcription of 
class II genes has been shown to be transiently 
upregulated after activation of dendritic cells (DCs), 
followed by a complete shut down (Cella et al., 1997; 
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Rescigno et al., 1998; Landmann et al., 2001; Pai et 
al., 2002; Wilson et al., 2004). Considering the in 
general elevated expression of Ii as compared to 
MHC class II, this could provide an opportunity for 
replacement of these potentially autoimmune 
provoking molecules. Certainly this would not be the 
only mechanism operating, considering the general 
redundancy in biological systems, and the potential 
importance of such a mechanism in relation to 
autoimmunity. Indeed, DCs isolated from Ii null mice 
have been shown to display errant transport of some 
MHC class II alleles whilst others traffic normally 
and display MHC class II as Ii+/+cells (Rovere et al., 
1998). The numerous studies implying variations in 
nt on intact 
pcDNA3 (Invitrogen) as a HindIII-EcoRI fragment. The TfR-Ii 
e Kidney (MDCK) strain II cells and human 
roblast (M1) cells were grown in complete medium: DMEM 
ed with 10% FCS 
M L-glutamine, 25 
 
meå, 
116-32 is a mouse monoclonal IgG2b antibody 
ondary antibodies in 0.1% 
t G 
endosomal pH, alterations in cathepsin activity 
(Trombetta et al., 2003) and Ii processing (Pierre and 
Mellman, 1998) following activation of DCs provide 
additional incentive for considering this property of Ii 
in relation to this proposed mechanism.  
Adding to this, it can not be excluded that Ii might 
contribute to the retention of MHC class II 
intracellularly in immature DCs (reviewed in 
references) (Trombetta and Mellman, 2005; Wilson 
and Villadangos, 2005). Certainly a high expression 
level of Ii, as has been described for imDCs 
(Kampgen et al., 1991), would ensure a rapid turnover 
of cell surface class II. A transient upregulation upon 
activation would facilitate removal of self-peptide 
loaded class II. And a shut-down of class II gene 
transcription would, after Ii degradation, enable the 
significantly longer-lived class II molecules to 
transport to, and remain stably at, the cell surface. At 
the cell surface they would then present the widest 
possible array of peptides, as promoted by Ii directed 
trafficking.  
In summary, we show that Ii in excess is able to 
accelerate the endocytosis of mature, cell surface 
expressed, MHC class II. The effect is specific for 
class II, and not a bi-effect of Iis membrane acquiring 
properties. The internalized class II molecules are 
distributed to intracellular compartments where they 
colocalize with the lysosomal marker LAMP1. We 
find that the internalization is independent on sorting 
signals in MHC class II, but dependa
signals in Ii. And we find that the various class II 
interacting lumenal domains of Ii contribute and sum 
up to the effect. 
 
Materials and methods: 
cDNA constructs: 
The plasmids pFM339 and pFM340, containing I-Akα and I-
Akβ respectively, are derived from the eukaryotic expression 
vector pHbetaAPr-1-neo and have been previously 
described(Gregers et al., 2003). HLA-DR1α and HLA-DR3β 
were obtained from the HLA-DR1a and # 69 DRα IRES 
DR3β-CFP (kindly provided by Alexander Griekspoor) 
constructs respectively. HLA-DR1α was subcloned into 
pPAGFP-N1 (courtesy of Jennifer Lippincott-Schwartz) using 
EcoRI-BamHI restriction sites, generating a fusion protein with 
a DPPVAT linker sequence. HLA-DR3 β was subcloned into 
fusion protein consists of the cytoplasmic tail and 
transmembrane domains from human Ii (p33), fused in-frame 
to the luminal part of the human transferrin receptor, and 
subcloned into pMEP4 as a KpnI-BamHI fragment. cDNA 
encoding Ii-wt, IiD6R and Ii∆20 have been described 
previously (Bakke and Dobberstein, 1990; Simonsen et al., 
1997; Gregers et al., 2003), and were subcloned into the 
pMep4 vector (Invitrogen) as KpnI-BamHI fragments. pMep4 
with an Ii construct where the CLIP region is replaced with a 
sequence derived from hemagglutinine (HA); YPYDVPDYA, 
was a gift from Vibeke Årskog (University of Oslo, Norway). 
The C-terminal deletion mutants were generated by PCR 
(using pSV51L-Ii as a template) and subcloned into pMep4 as 
KpnI-BamHI fragments. All constructs were verified by 





(Bio Whittaker, MD, USA) supplement
(Integro b.v., Zaandam, Netherlands), 2 m
U/ml penicillin and 25 µg/mL streptomycin (Bio Whittaker).
MDCK cells stably transfected with human or mouse MHC 
class II, with or without Ii, MDCKHLA-DR/Ii-wt, MDCKHLA-DR∆/Ii-wt 
and MDCKI-Ak/Ii-wt, MDCKI-Ak, respectively, have been 
described previously (Simonsen et al., 1999; Gregers et al., 
2003). These cells were grown in complete medium 
containing 0.2 mg/mL G418 bisulphate (Duchefa, Haarlem, 
Netherlands) and 0.15 mg/mL Hygromycin B (Saaven, 
Sweden). Stable transfections were carried out with the 
Lipofectamin 2000 reagent (Invitrogen) according to supplied 
protocol. Positive clones were selected in 0.3 mg/mL G418, 
0.3 mg/mL Hygromycin B, expression of ILEVs after adding 
25 µM CdCl2 over-night, or fluorescent signal. Clones 
expressing the relevant constructs were picked with cloning 
cylinders, generating the MDCKβαPA, MDCKIi+βαPA , M1HLA-DR, 
M1HLADR∆ and M1I-Ak, cell-lines. 
 
Antibodies, antigens, fluorescent probes and T cells: 
BU43 is a mouse IgM monoclonal antibody (mAb) specific for 
the C-terminal (lumenal/extracellular) domain of Ii (D. Harding, 
Birmingham, UK). The BU45-HPSF1 hybridoma was kindly 
supplied by S. Buus (Copenhagen, Denmark), it produces the 
mouse mAb BU45 (Wraight et al., 1990) which also 
recognizes the C-terminal domain of Ii. BU45 was directly 
labeled with alexa 546 (Molecular Probes, Eugene, UK) 
according to the supplied protocol. The rabbit anti-LAMP1 
polyclonal antibody was a gift from S. Carlsson (U
Sweden). H
specific for mouse I-Ak (Koch et al., 1982), and was provided 
by F. Momburg (Heidelberg, Germany). Mouse monoclonal 
L243 (American Type Culture Collection, Manassas, VA, 
USA) recognizes HLA-DR (Lampson and Levy, 1980). Goat 
anti-mouse IgG Alexa 488/594, goat anti-rabbit Alexa 488 and 
Transferrin-alexa 647 conjugate were purchased from 
Molecular probes (OR, USA). Texas-red conjugated goat anti-
mouse IgM was obtained from Southern Biotechnology 
Associates Inc. (AL, USA). IB9 is a T cell hybridoma which 
recognizes a peptide derived from Hen Egg Lysozyme (HEL, 
116-129) bound to I-Ak (Zhong et al., 1997). 1B9 T cell 
hybridoma and synthetic peptide were both provided by R. 
Germain (Bethesda, MD, USA). 
 
Immunofluorescence- and confocal laser scanning 
microscopy: 
Cells were grown confluent on coverslips and induced to 
express Ii with 25µM CdCl2 for the defined time periods, then 
allowed to internalize BU43 prior to fixation in 3% 
paraformaldehyd (PFA). Cells were stained with the 
appropriate primary and sec
saponine in 1xPBS before mounting in Fluoromoun
(Southern Biotechnology Associates, Birmingham, AL, USA) 
or Moviol medium (Sigma-Aldrich). Immunofluorescence 
microscopy was performed on a Leica TCS-NT digital 
scanning confocal microscope equipped with a 60/1.2 
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immersion objective (Leica, Bensheim, Germany) or an 
Olympus FV1000 scanning laser confocal microscope 
equipped with a 60/1.1 oil immersion objective (Olympus, 
Hamburg, Germany). Fluorochromes were exited with the 
appropriate laser lines; 488 nm Argon, 543 nm and 647 nm 
HeNe lasers. PAGFP was activated with the 405 nm laser and 
imaged as GFP with the 488 nm argon laser. For the “Ii 
chase” time-lapse imaging experiments, MDCKIi+βαPA and 
MDCKβαPA were seeded out in glass bottom microwell dishes 
(MatTek Corporation, Ashland, USA), medium was 
exchanged for DMEM without phenol red (Bio Whittaker, MD, 
USA) supplemented with FCS, LG and PS and added the 
BU45-alexa546 conjugate 1 hour before imaging. MHC class 
II-PAGFP was photoactivated and allowed to exit the 
ER/distribute to the cell surface for 1 hour before Ii was 
induced. The TfR-Ii chase was conducted on the MDCKβαPA 
cells transiently transfected with the TfR-Ii construct, and 
15µM CdCl2 and the transferrin-alexa 647 conjugate was 
added to the medium for 2 hours before imaging to detect 
positive cells. All time-lapse imaging was conducted on the 
lympus (se above) with images obtained every 3 minutes at 
6 nm at 9-45%power and 647 nm at 9-45% 
dy was calculated as the 
body resistant to low pH acid wash relative to the antibody 
 the onset of the chase period. 
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power depending on expression level and fluorochrome, but 
kept at a constant level throughout the experiments. Images 
were processed with Adobe Photoshop and Premiere (Adobe 
systems Inc., CA, USA), ImageJ (NIH, USA) and Imaris 
(Bitplane AG, Zurich, Switzerland). 
 
Iodination: 
The anti I-Ak antibody H116-32 was iodinated using IODO-
Gen pre-coated iodination tubes (Pierce, IL, USA) as 
described by the manufacturer. Briefly 100µg protein was 
incubated with 40 MBq Na125I for 1 hour at room temperature. 
Iodinated proteins were separated from free Na125I and 
unincorporated 125I2 on sephadex G-25M columns (Amersham 
Pharmacia Biotech, Uppsala, Sweden). The specific activity of 
the labeled proteins was determined by trichloracetic acid 
precipitation. The amount of soluble radioactivity in the 
fractions used was less than 5% of total radioactivity. 
 
Quantification of surface bound I-Ak: 
For quantification of surface bound I-Ak, MDCKI-Ak/Ii-wt cells 
were seeded at 5x105 cells per well in a 6 well, and incubated 
with 25µM CdCl2 at different time points. The cells were 
washed twice in ice cold PBS and incubated on ice with 125I-
H116-32 in 0.5 mL PBS (2µg/mL) for 45 minutes. Unbound 
antibody was removed by washing twice in ice cold PBS with 
1%BSA. Cell surface bound antibody was collected by 
treatment with 0.5M acetic acid in 0.15M NaCl (pH2.5) for 
7minutes. To ensure that no antibody was internalized during 
incubation on ice, the cells were also lysed in 1M NaOH for 10 
minutes. Lysate and acid wash were counted in a COBRA γ 
counter (Packard Instrument Company, Meriden, CT, USA). 
10µg/mL cyclohexamide was added to the cells for up to 6 
hours to inhibit protein synthesis. For the I-Ak internalization 
experiments, MDCKI-Ak/Ii-wt cells were seeded and treated 
essentially as above, however after the PBS/BSA wash, the 
cells were chased in complete medium at 37ºC for different 
time periods. Then the cells were chilled on ice, washed and 





MDCKI-Ak/Ii-wt were used as antigen presenting cells and 
seeded at 5x103cells/well in 96 well plates, to avoid 
polarization. The cells were allowed to adhere over night 
before incubation with 25µM CdCl2 for 2, 6 and 24 hours to 
induce expression of Ii. The cells were then fixed in 1% PFA 
for 20 minutes at room temperature, washed extensively and 
subsequently incubated for 24 hours at 37ºC with 10µg/mL 
HEL 116-129 and 5x104 cells/well 1B9 T cell hybridomas
ce
production of IL-2 and proliferation of
dependant) which were pulsed with 1µCi 3H-thymidine over 
night, harvested and counted in a Matrix96 β-counter 
(Packard Instrument Company, Meriden, CT, USA). 
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